{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:18:52Z","timestamp":1778656732675,"version":"3.51.4"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T00:00:00Z","timestamp":1268697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Vincristine plus steroid pulses have long been a part of maintenance treatment in many protocols for childhood acute lymphoblastic leukaemia (ALL). A collaborative individual patient data meta\u2010analysis of all randomised trials of the addition of vincristine plus prednisone\/prednisolone (VP) pulses in childhood ALL was updated and extended to include trials comparing vincristine plus dexamethasone (VD) pulses to maintenance without pulses. VP pulses improved event\u2010free survival (EFS) (70\u00b71% vs. 62\u00b70% at 5\u2003years; odds ratio (OR)\u2003=\u20030\u00b771; 95% confidence interval (CI)\u2003=\u20030\u00b761\u20130\u00b784; <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b700004); VD pulses did not have a significant effect (80\u00b79% vs. 79\u00b79% 5\u2003year EFS; OR\u2003=\u20030\u00b794; 95% CI\u2003=\u20030\u00b780\u20131\u00b711; <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b75). Heterogeneity between groups (VP or VD) was significant (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b702). Neither treatment clearly affected overall survival. The difference between the VP and VD results is probably due to the greater early intensity of the backbone of the VD trial protocols and improved outcome seen in the VD trials, which were more recent. Pulses may still be useful in cases where less intensive early therapy is used and the balance between these treatments in terms of both effectiveness and toxicity needs to be considered.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08148.x","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T08:14:17Z","timestamp":1268727257000},"page":"722-733","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia \u2013 an individual patient data meta\u2010analysis involving 5659 children"],"prefix":"10.1111","volume":"149","author":[{"name":"Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,17]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.3927"},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.V42.3.349.349","article-title":"Comparison of two methods of preventing central nervous system leukemia","volume":"42","author":"Aur R.J.","year":"1973","journal-title":"Blood"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.5.317"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.6.1012"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2454"},{"key":"e_1_2_7_7_1","unstructured":"Cancer and Leukemia Group B. (1972)Chemotherapy with 6\u2010MP\/PRED and 6\u2010MP 6\u2010MP\/VCR\/PRED 6\u2010MP\/DNM\/PRED or 6\u2010MP\/DNM\/PRED\/VCR for Acute Lymphocytic Leukemia in Children. In Clinical Trials (PDQ) [Internet]. National CancerInstitute (US). [Cited 2010 Jan 14]. Available from:http:\/\/www.cancer.gov\/search\/viewclinicaltrials.aspx?cdrid=70798&version=healthprofessional&protocolsearchid=7218747."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3113127.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91615-3"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07624.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.06.005"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60073-7"},{"key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.V112.11.11.11","article-title":"Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951","volume":"112","author":"De Moerloose B.","year":"2008","journal-title":"Blood"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197511)36:5<1552::AID-CNCR2820360503>3.0.CO;2-3"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1033805"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197212)30:6<1480::AID-CNCR2820300611>3.0.CO;2-3"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.825"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05509.x"},{"key":"e_1_2_7_19_1","first-page":"163","article-title":"Spanish acute lymphoblastic leukaemia trials","volume":"5","author":"Ortega J.J.","year":"1998","journal-title":"International Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn276"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.9.2817"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.07.002"},{"key":"e_1_2_7_23_1","first-page":"125","article-title":"Childhood acute lymphoblastic leukemia in the Netherlands","volume":"5","author":"Van der Does Van den Berg A.","year":"1998","journal-title":"International Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70228-1"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08148.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08148.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:35:37Z","timestamp":1697394937000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08148.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,17]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08148.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08148.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,17]]},"assertion":[{"value":"2010-05-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}